Xianglin Zhang

Prof. Xianglin Zhang

Huazhong University of Science and Technology, Wuhan, Hubei, China
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
WAWaeljumah Aljohani
Waeljumah Aljohani
Muhammad Wajid UllahMuhammad Wajid Ullah
Muhammad Wajid Ullah
Xianglin ZhangXianglin Zhang
Xianglin Zhang
Guang YangGuang Yang
Guang Yang

31 May 2019 in Biofabrication
Verified
Journal Article
Closed access
PDF file
LSLei Shi
Lei Shi
YHYiqiang Hu
Yiqiang Hu
Muhammad Wajid UllahMuhammad Wajid Ullah
Muhammad Wajid Ullah
Ismat UllahIsmat Ullah
Ismat Ullah
HOHao Ou
Hao Ou
Xianglin ZhangXianglin Zhang
Xianglin Zhang
A novel strategy of cryogenic 3D bioprinting assisted by free-from extrusion printing has been developed and applied to printing of a decellularized small intestinal submucosa (dSIS) slurry. The rheological properties, including kinetic viscosity, storage modulus (G′), and loss modulus (G″), were appropriate for free-from extrusion printing of dSIS slurry. Three different groups of scaffolds, including P 500 , P 600 , and P 700 , with filament distances of 500, 600, and 700 μ m, respectively were fabricated at a 5 mm s −1 working velocity of the platform ( V xy ) and 25 kPa air pressure of the dispensing system ( P ) at −20 °C. The fabricated scaffolds were crosslinked via 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) which resulted in a polyporous microstructure. The variations in the filament diameter and pore size were evaluated in the initial frozen state after printing, the lyophilized state, and after immersion in a PBS solution. The Young’s modulus of the P 500 , P 600 , and P 700 scaffolds was measured in wet and dry states for EDC-crosslinked scaffolds. The cell experiment results showed improved cell adhesion, viability, and proliferation both on the surface and within the scaffold, indicating the biocompatibility and suitability of the scaffold for 3D cell models. Further, gene and protein expression of normal skin fibroblasts on dSIS scaffolds demonstrated their ability to promote the production of some extracellular matrix proteins (i.e. collagen I, collagen III, and fibronectin) in vitro . Overall, this study presents a new potential strategy, by combining cryogenic 3D bioprinting with decellularized extracellular matrix materials, to manufacture ideal scaffolds for skin tissue engineering applications.

1 May 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Ismat UllahIsmat Ullah
Ismat Ullah
WZWancheng Zhang
Wancheng Zhang
LYLiang Yang
Liang Yang
Muhammad Wajid UllahMuhammad Wajid Ullah
Muhammad Wajid Ullah
OAOmar Mohammad Atta
Omar Mohammad Atta
Xianglin ZhangXianglin Zhang
Xianglin Zhang

1 November 2021 in Bioactive Materials
Verified
Journal Article
Open access
TSTingfang Sun
Tingfang Sun
CMChunqing Meng
Chunqing Meng
QDQiuyue Ding
Qiuyue Ding
KYKeda Yu
Keda Yu
Xianglin ZhangXianglin Zhang
Xianglin Zhang
ZXZekang Xiong
Zekang Xiong
In situ tissue engineering is a powerful strategy for the treatment of bone defects. It could overcome the limitations of traditional bone tissue engineering, which typically involves extensive cell expansion steps, low cell survival rates upon transplantation, and a risk of immuno-rejection. Here, a porous scaffold polycaprolactone (PCL)/decellularized small intestine submucosa (SIS) was fabricated via cryogenic free-form extrusion, followed by surface modification with aptamer and PlGF-2123-144*-fused BMP2 (pBMP2). The two bioactive molecules were delivered sequentially. The aptamer Apt19s, which exhibited binding affinity to bone marrow-derived mesenchymal stem cells (BMSCs), was quickly released, facilitating the mobilization and recruitment of host BMSCs. BMP2 fused with a PlGF-2123-144 peptide, which showed “super-affinity” to the ECM matrix, was released in a slow and sustained manner, inducing BMSC osteogenic differentiation. In vitro results showed that the sequential release of PCL/SIS-pBMP2-Apt19s promoted cell migration, proliferation, alkaline phosphatase activity, and mRNA expression of osteogenesis-related genes. The in vivo results demonstrated that the sequential release system of PCL/SIS-pBMP2-Apt19s evidently increased bone formation in rat calvarial critical-sized defects compared to the sequential release system of PCL/SIS-BMP2-Apt19s. Thus, the novel delivery system shows potential as an ideal alternative for achieving cell-free scaffold-based bone regeneration in situ.

18 December 2017 in Polymer Engineering & Science
Verified
Journal Article
Closed access
PDF file
LSLei Shi
Lei Shi
LXLiming Xiong
Liming Xiong
YHYiqiang Hu
Yiqiang Hu
WLWenchao Li
Wenchao Li
ZCZhiChao Chen
ZhiChao Chen
Xianglin ZhangXianglin Zhang
Xianglin Zhang

2 April 2021 in Biofabrication
Verified
Journal Article
Closed access
PDF file
LYLiang Yang
Liang Yang
Ismat UllahIsmat Ullah
Ismat Ullah
KYKeda Yu
Keda Yu
WZWancheng Zhang
Wancheng Zhang
JZJinge Zhou
Jinge Zhou
XGXiaodong Guo
Xiaodong Guo
Developing multi-doped bioceramics that possess biological multifunctionality is becoming increasingly attractive and promising for bone tissue engineering. In this view innovative Sr 2+ /Fe 3+ co-substituted nano-hydroxyapatite with gradient doping concentrations fixed at 10 mol% has been deliberately designed previously. Herein, to evaluate their therapeutic potentials for bone healing, novel gradient SrFeHA/PCL scaffolds are fabricated by extrusion cryogenic 3D printing technology with subsequent lyophilization. The obtained scaffolds exhibit desired 3D interconnected porous structure and rough microsurface, along with appreciable release of bioactive Sr 2+ /Fe 3+ from SrFeHA components. These favorable physicochemical properties render printed scaffolds realizing effective biological applications both in vitro and in vivo , particularly the moderate co-substituted Sr7.5Fe2.5HA and Sr5Fe5HA groups exhibit remarkably enhanced bioactivity that not only promotes the functions of MC3T3 osteoblasts and HUVECs directly, but also energetically manipulates favorable macrophages activation to concurrently facilitate osteogenesis/angiogenesis. Moreover, in vivo subcutaneous implantation and cranial defects repair outcomes further confirm their superior capacity to dictate immune reaction, implants vascularization and in situ bone regeneration, mainly dependent on the synergetic effects of released Sr 2+ /Fe 3+ . Accordingly, for the first time, present study highlights the great potential of Sr7.5Fe2.5HA and Sr5Fe5HA for ameliorating bone regeneration process by coupling of immunomodulation with enhanced angio- and osteogenesis and hence may provide a new promising alternative for future bone tissue engineering.